🇺🇸 FDA
Pipeline program

Fentanyl Buccal Tablet (FBT)

C25608/4027/BP/EU

Approved small_molecule terminated

Quick answer

Fentanyl Buccal Tablet (FBT) for Cancer Pain is a Approved program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Cancer Pain
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials